Feed / MNTN

MNTN, Inc.

MNTN

Technology · 12.79 -0.8% today

Isolated · not yet confirmedMarket checked 8 Sept, 15:55 GMT-4

Market read

MNTN, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 5 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.

Company-0.8% todayVolume comparison unavailable
Market group0 of 5 activeBiotech and Tech Services · unavailable
Disclosed network0 of 2 confirmingNo filing-linked name is confirming now
What would change this read
  • MNTN's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if MNTN's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Technology · Software - Application

No new filing conclusion is available. 0 of 5 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • MNTN's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 9, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods2
Price observations317
Usable filing statements117
Verified relationships0
Evidence supporting the case
  • Latest annual revenue changed +28.6% year over year.
  • Operating margin changed +9.0 percentage points in the latest annual period.
  • Net margin changed +12.4 percentage points in the latest annual period.
Evidence challenging the case

No qualifying adverse evidence was identified; that is not proof there is no downside.

Questions before a position
  • EV/sales is 45% below the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 8, 2026

12.79
6m+32.5%12m-39.5%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2024-12-31$225.6M$-2.38
2025-12-31$290.1M+28.6%$-0.13

What management says matters

Persistent and emerging business drivers

Credit and interest ratesmixed · 4 filings
The favorable change was primarily due to a decrease in interest expense on the Convertible Notes of $1.6 million which were settled on May 23, 2025, resulting in no interest expense for the three months ended March 31, 2026.
10-Q · May 11, 2026
Macroeconomic conditionsmixed · 4 filings
Impact of Inflation While it is difficult to accurately measure the impact of inflation due to the imprecise nature of the estimates required, we do not believe inflation has had a material effect on our historical results of operations and financial conditio…
10-Q · May 11, 2026
Legal and regulatory exposurepositive · 2 filings
The increase was primarily due to an increase in legal costs of $2.9 million related to transactions and litigation work and increased merchant service fees of $2.3 million driven by increased revenue volume.
10-K · Feb 19, 2026
Restructuring and cost reductionsmixed · 1 filings
Personnel 36 Table of Contents costs increased $1.0 million driven by $0.7 million increase in bonus and commission costs coupled with a $0.2 million increase in severance costs.
10-Q · Aug 11, 2025

Valuation discipline

Descriptive valuation snapshot

Price/sales 2.2× · EV/sales 1.5×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Fewer than 4 annual revenue periods; too little history to scaffold scenarios.

Price action

How the market is pricing the story

12.79-0.8% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 8 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for MNTN. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for MNTN. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind MNTN

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

MNTN is currently a Leader in the organic co-movement group Biotech and Tech Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.

This group is retained as the last observed read for MNTN; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.